1995
DOI: 10.1097/00042192-199502010-00003
|View full text |Cite
|
Sign up to set email alerts
|

Estrogen Increases Cerebral and Cerebellar Blood Flows in Postmenopausal Women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
56
0

Year Published

2000
2000
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 93 publications
(57 citation statements)
references
References 0 publications
1
56
0
Order By: Relevance
“…30,[34][35][36][37] CBF in the gray matter is significantly greater in women compared with men until the sixth decade of life 33,34,38,39 when losses of vascular and neuroprotective estrogen result in reductions in CBF in postmenopausal women. 40 However, interactions between age and sex on white matter CBF across the lifespan remain unknown. This is clinically significant given the link between elevations in aortic stiffness and development of white matter hyperintensities.…”
Section: Discussionmentioning
confidence: 99%
“…30,[34][35][36][37] CBF in the gray matter is significantly greater in women compared with men until the sixth decade of life 33,34,38,39 when losses of vascular and neuroprotective estrogen result in reductions in CBF in postmenopausal women. 40 However, interactions between age and sex on white matter CBF across the lifespan remain unknown. This is clinically significant given the link between elevations in aortic stiffness and development of white matter hyperintensities.…”
Section: Discussionmentioning
confidence: 99%
“…Estrogen is considered to 1) improve the depressive status [6], 2) increase the brain blood flow [7], 3) stimulate the cholinergic neurons [8][9][10], and 4) increase the number of developed glial cells [11]. The prevention of arteriosclerosis is considered to be one of the important effects of estrogen to protect the brain, because AD and vascular dementia of the small vessel type frequently show overlap both in clinical symptoms and histological findings [12].…”
Section: Introductionmentioning
confidence: 99%
“…5 ± 7 However, large placebo-controlled trials and well-designed epidemiological studies are required to address the role of oestrogens in prevention and treatment of AD as there have also been negative studies. 8 Oestrogen has been reported to increase the non-amyloidogenic processing of APP, 9 up-regulate the Apolipoprotein E gene (APOE) expression, 10 improve cerebral blood flow, 11 facilitate neuronal repair, reduce neuronal injury and stimulate glucose transport and metabolism. 12 An association to AD has been reported for the oestrogen receptor a (ERa) gene in several studies 13,14 but there has also been a negative report.…”
Section: Introductionmentioning
confidence: 99%